Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to test the hypothesis that exenatide QW given once weekly for 26 weeks is superior to a titration of insulin detemir, given once or twice daily (titrated to reach a target of pre-breakfast and pre-dinner glucose concentrations of <5.5 mmol/L) when given for 26 weeks in the treatment of patients with type 2 diabetes not adequately controlled using OAD therapy. The primary efficacy measure will be assessed by the proportion of patients on each therapy who have achieved HbA1c concentration ≤7.0% with weight loss (≥1.0 kg) at endpoint.
Critère d'inclusion
- diabetes